Mount Sinai St. Luke's Hospital — New York, New York

Mount Sinai St. Luke's Hospital is a clinical research site located in New York, New York, United States 10019.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Mount Sinai St. Luke's Hospital has participated in 6 clinical trials.

Therapeutic areas: Lung Cancer, Venous Leg Ulcer, Type 2 Diabetes.

Sponsors: Icahn School of Medicine at Mount Sinai, MediWound Ltd, GRADE Study Group.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai St. Luke's Hospital?

Mount Sinai St. Luke's Hospital has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai St. Luke's Hospital conducted?

Mount Sinai St. Luke's Hospital has 6 clinical trials on record. Their work covers Lung Cancer, Venous Leg Ulcer, Type 2 Diabetes.

Is Mount Sinai St. Luke's Hospital accredited by Crixeo Health?

Yes — Mount Sinai St. Luke's Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mount Sinai St. Luke's Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.